Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tae Kyu Chung"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 21022-21031 (2023)
Abstract Background Rising costs of cancer treatments challenge even areas with universal health coverage. There's a need to assess current medical care utilization trends among patients with cancer to guide public health policy, resource allocation,
Externí odkaz:
https://doaj.org/article/7f316edff1dc4917b8e5787f65433793
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 9, Pp 1223-1233 (2022)
Abstract YH4808 is a novel potassium‐competitive acid blocker that is under clinical development to treat patients with gastroesophageal reflux disease and peptic ulcer diseases. In this study, the pharmacokinetic (PK) and pharmacodynamic (PD) prof
Externí odkaz:
https://doaj.org/article/a46225f11b7940b0b050b4ca26983637
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
As frequent changes in anti-hypertensive (HTN) medications may reduce adherence to the treatments, identifying modifiable factors leading to changes in anti-HTN medications can help clinicians optimize treatment strategies for individual patients. We
Externí odkaz:
https://doaj.org/article/ba8f7e6634b9444f8033b0caa94d1526
Autor:
Tae Kyu Chung, Hyun A. Lee, Sang‐In Park, Do‐Youn Oh, Keun‐Wook Lee, Jin Won Kim, Jee Hyun Kim, Ahmi Woo, Su Jin Lee, Yung‐Jue Bang, Howard Lee
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 990-1001 (2021)
Abstract GC1118 is a monoclonal antibody for epidermal growth factor receptor (EGFR) that is currently under clinical development to treat patients with solid tumors. In this study, the pharmacokinetics (PKs) of GC1118 were modeled in solid tumor pat
Externí odkaz:
https://doaj.org/article/97fddf7fd5a74baeaae997875bc98093
Autor:
Jin Won Kim, Keun Wook Lee, Howard Lee, Jee Hyun Kim, Yung-Jue Bang, Ahmi Woo, Tae Kyu Chung, Sang In Park, Su Jin Lee, Do Youn Oh, Hyun A. Lee
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 990-1001 (2021)
Clinical and Translational Science
Clinical and Translational Science
GC1118 is a monoclonal antibody for epidermal growth factor receptor (EGFR) that is currently under clinical development to treat patients with solid tumors. In this study, the pharmacokinetics (PKs) of GC1118 were modeled in solid tumor patients who